Zobrazeno 1 - 7
of 7
pro vyhledávání: '"329"'
Autor:
Neel Raja, Oliver C Cohen, Aoife Dervin, Max Brodermann, S Morley, Kirit M. Ardeshna, Ian Proctor, William Townsend
Publikováno v:
Blood. 134:4746-4746
Introduction Lymph node excision has historically been preferred to core biopsy in diagnosing lymphoma given reported higher diagnostic yield and concerns that core biopsies yielded insufficient material. However, core biopsy is associated with lower
Autor:
Myriam Rodríguez, Abel Berrios, Denisse Castro, Maria Elena Cabrera, Camila Peña, Carlos S. Chiattone, Victoria Otero, Fabiola Valvert Gamboa, Raul Gabus, Marialejandra Torres Viera, Teodoro Chisesi, Gregorio Ignacio, Brady E Beltran, Eduardo M. Sotomayor, Gabriel Borelli, Jorge J. Castillo, Sally Rose Paredes
Publikováno v:
Blood. 132:5395-5395
Introduction: Diffuse large B-cell lymphoma (DLBCL) is the most frequent subtype of lymphoma in the world and corresponds to a heterogeneous entity, both from the clinical and molecular point of view, being its prognosis of survival very variable The
Autor:
Sally Rose Paredes, Myriam Rodríguez, Maria Elena Cabrera, Victoria Otero, Brady E Beltran, Fabiola Valvert Gamboa, Carlos S. Chiattone, Teodoro Chisesi, Raul Gabus, Gregorio Ignacio, Gabriel Borelli, Denisse Castro, Jorge J. Castillo, Camila Peña, Abel Berrios, Eduardo M. Sotomayor, Marialejandra Torres Viera
Publikováno v:
Blood. 132:2987-2987
Introduction: Diffuse large B-Cell Lymphoma (DLBCL) is the most frequent subtype of lymphoma in the world. The IPI score is a powerful risk-stratification tool in patients with DLBCL. The neutrophil-to-lymphocyte ratio (NLR) has shown to be prognosti
Autor:
Erin Morris, John S. Holcenberg, F. Leonard Johnson, Stanton Goldman, Raymond J. Hutchinson, Jerry Z. Finklestein, Susan G. Kreissman, Elizabeth Harvey, Conrad Tou, Mitchell S. Cairo
Publikováno v:
Blood. 97:2998-3003
Standard therapy in the United States for malignancy-associated hyperuricemia consists of hydration, alkalinization, and allopurinol. Urate oxidase catalyzes the enzymatic oxidation of uric acid to a 5 times increased urine soluble product, allantoin
Autor:
Markus Loeffler, Norbert Schmitz, Randy D. Gascoyne, Roopesh Kansara, Michael Pfreundschuh, Bertram Glass, Samira Zeynalova, Kerry J. Savage, David Scott, Diego Villa, Laurie H. Sehn, Joseph M. Connors, Maike Nickelsen, Marita Ziepert
Publikováno v:
Blood. 124:394-394
[Graphic][1] Introduction : Despite the improvement of outcome of aggressive B-cell lymphomas in the rituximab treatment era, central nervous system (CNS) relapse continues to pose a significant management problem. It remains a challenge to select pa
Autor:
Jana Markova, Andreas Engert, Richard Herrmann, Peter Borchmann, Rolf P. Mueller, Bernd Doerken, Michael Fuchs, Annette Pluetschow, Hans Konrad Mueller-Hermelink, Hans Theodor Eich, Volker Diehl, Lothar Kanz, Richard Greil
Publikováno v:
Blood. 114:716-716
Abstract 716 Background: There has been an ongoing debate on the best treatment for patients with early favourable Hodgkin lymphoma (HL). Open questions include the choice between combined modality treatment or chemotherapy only, the number of chemot
Autor:
Susana Perdomo, Cecilia Guillermo, Lilián Díaz, Martha Nese, Alberto Baubeta, Laura Topolansky, Andrea Diaz, Mariana Stevenazzi, Ana Perdomo, Hugo Isaurralde, Graciela Lavagna, Juan Zunino
Publikováno v:
Blood. 108:5430-5430
Between 1995 and 2005, we performed 329 hematopoietic stem cell transplantation (HSCT), 286 autoulogous and 43 allogeneic. Long term results of treatment and outcome of ASCT in 100 Non Hodgkin Lymphoma (NHL) were analyzed. Median age was 47 years (ra